Abstract
To assess the prevalence of colourings and preservatives in drug formulations in the United Kingdom. Postal survey. All pharmaceutical manufacturers in the United Kingdom were requested to supply data on drug formulations with particular regard to the content of colourings and preservatives. Prevalence in proprietary drugs of colourings or preservatives, or both, that have been implicated in adverse reactions. Computation of a list of formulations of bronchodilators, antihistamines, and antibiotics that are free of such additives. A total of 118 out of 120 pharmaceutical companies supplied the data requested. In all, 2204 drug formulations were analysed and found to contain 419 different additives, of which 52 were colourings and preservatives that have been implicated in adverse reactions; 930 formulations contained such an additive. Tartrazine was the fourth most commonly occurring colouring, being present in 124 drug formulations. Many drugs contain additives that help to identify them and prolong their shelf life but are implicated in adverse reactions in some people. Some form of labelling of drug additives would enable these people to avoid drugs containing such additives.
References
Jul 1, 1979·The Journal of Allergy and Clinical Immunology·R W WeberH S Nelson
Apr 11, 1977·JAMA : the Journal of the American Medical Association·J E NagelP Fireman
Jun 1, 1976·The Journal of Allergy and Clinical Immunology·G A SettipaneD E Klein
Jul 1, 1976·The British Journal of Dermatology·A M RosG Michaëlsson
Aug 21, 1976·Canadian Medical Association Journal·W R Bartle
Oct 1, 1976·The Journal of Allergy and Clinical Immunology·L J Smith, R G Slavin
Mar 9, 1985·Lancet·J EggerJ F Soothill
Oct 18, 1986·Lancet·G Supramaniam, J O Warner
Mar 1, 1988·British Journal of Clinical Pharmacology·R BeasleyS T Holgate
Feb 1, 1987·Archives of Disease in Childhood·T J David
Nov 1, 1987·The Journal of Allergy and Clinical Immunology·P J GergenM G Kovar
Jun 1, 1973·The British Journal of Dermatology·G Michaëlsson, L Juhlin
Apr 1, 1969·The Journal of Allergy·R E Reisman
Aug 14, 1982·Lancet·P JenkinsP A Emerson
Oct 1, 1984·The Journal of Allergy and Clinical Immunology·R A Simon
May 15, 1982·British Medical Journal·R P Warin, R J Smith
Jul 1, 1981·The Journal of Allergy and Clinical Immunology·D D Stevenson, R A Simon
Citations
Jul 24, 2003·Il Farmaco·Giorgio Pifferi, Patrizia Restani
Jul 1, 1997·Clinics in Dermatology·D P Bruynzeel, H I Maibach
Oct 28, 1989·BMJ : British Medical Journal·F Wells
Sep 25, 1993·BMJ : British Medical Journal·M L KulkarniV Venkataramana
Aug 30, 2007·The Journal of Pharmacy and Pharmacology·Terry B ErnestJames L Ford
Sep 29, 2001·Anaesthesia·R D MacPherson
Nov 1, 2001·The Cochrane Database of Systematic Reviews·K D Ardern, F S Ram
Sep 25, 1993·BMJ : British Medical Journal·N J BundredJ M Morrison
Jul 30, 2019·Journal of Food Biochemistry·Haddad A El RabeyFahad M Almutairi
Aug 2, 2019·BMC Gastroenterology·Cheng XieYu Fu